Hirsutism and Virilization in the Female

    January 2013 in “ Elsevier eBooks
    Michael J. Wheeler
    Image of study
    TLDR The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.
    The chapter reviewed the causes and underlying steroid pathways of hirsutism and virilization in women, discussing conditions such as hypertrichosis, polycystic ovarian syndrome, idiopathic hirsutism, androgen-secreting tumors, congenital adrenal hyperplasia, and Cushing’s syndrome. It detailed the biological functions, clinical applications, and limitations of immunoassay analytes relevant to these conditions, including luteinizing hormone, follicle-stimulating hormone, anti-Mullerian hormone, testosterone, sex hormone-binding globulin, free testosterone, androstenedione, dehydroepiandrosterone sulfate, 17α-hydroxyprogesterone, dihydrotestosterone, and 3α-androstanediol glucuronide. The chapter also described typical assay technologies, sample types, usage frequency, and provided example reference intervals, with some information offered through cross-references to other chapters.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 24 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

      community Any balding females? I need advice with coping :(

       16 upvotes 8 years ago
      A 27-year-old woman is struggling with hair loss, feeling self-conscious and seeking advice on coping. She mentions trying Minoxidil but is hesitant due to scalp issues and is looking for ways to regain confidence.

    Related Research

    1 / 1 results